Axa’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-45,095
Closed -$13M 978
2025
Q2
$13M Buy
45,095
+3,013
+7% +$900K 0.04% 360
2025
Q1
$13M Sell
42,082
-5,730
-12% -$1.96M 0.04% 342
2024
Q4
$16.9M Sell
47,812
-15,037
-24% -$5.53M 0.05% 303
2024
Q3
$22.5M Sell
62,849
-2,191
-3% -$740K 0.07% 253
2024
Q2
$20.7M Buy
65,040
+8,208
+14% +$2.17M 0.06% 265
2024
Q1
$13.1M Buy
56,832
+3,461
+6% +$781K 0.04% 357
2023
Q4
$11.7M Buy
53,371
+4,537
+9% +$1.05M 0.04% 364
2023
Q3
$11M Sell
48,834
-140
-0.3% -$32.2K 0.04% 381
2023
Q2
$10.8M Buy
48,974
+673
+1% +$149K 0.04% 392
2023
Q1
$10.8M Sell
48,301
-1,209
-2% -$298K 0.04% 400
2022
Q4
$13.8M Buy
49,510
+838
+2% +$212K 0.05% 373
2022
Q3
$10.2M Buy
48,672
+4,412
+10% +$986K 0.04% 430
2022
Q2
$10.4M Buy
44,260
+34,260
+343% +$6.97M 0.04% 427
2022
Q1
$1.79M Sell
10,000
-32,293
-76% -$6.15M 0.01% 849
2021
Q4
$9.14M Buy
42,293
+4,000
+10% +$785K 0.02% 518
2021
Q3
$7.07M Buy
38,293
+17,800
+87% +$3.51M 0.02% 589
2021
Q2
$3.68M Sell
20,493
-42,100
-67% -$8.02M 0.01% 777
2021
Q1
$10.5M Sell
62,593
-59,900
-49% -$9.99M 0.03% 507
2020
Q4
$18.6M Sell
122,493
-31,800
-21% -$4.17M 0.06% 346
2020
Q3
$15.6M Buy
154,293
+26,719
+21% +$2.93M 0.06% 340
2020
Q2
$15.4M Buy
127,574
+44,167
+53% +$4.97M 0.06% 331
2020
Q1
$7.91M Sell
83,407
-10,693
-11% -$1.02M 0.04% 409
2019
Q4
$8.29M Buy
94,100
+82,500
+711% +$7.26M 0.03% 492
2019
Q3
$925K Sell
11,600
-38,900
-77% -$3.13M ﹤0.01% 995
2019
Q2
$3.94M Sell
50,500
-17,300
-26% -$1.62M 0.02% 713
2019
Q1
$7.96M Buy
67,800
+10,712
+19% +$1.25M 0.03% 516
2018
Q4
$6.22M Buy
57,088
+10,600
+23% +$1.23M 0.03% 548
2018
Q3
$5.95M Sell
46,488
-4,700
-9% -$581K 0.02% 623
2018
Q2
$5.79M Sell
51,188
-133
-0.3% -$14.6K 0.02% 617
2018
Q1
$5.77M Sell
51,321
-19,000
-27% -$2.41M 0.02% 612
2017
Q4
$10.4M Buy
70,321
+3,692
+6% +$469K 0.04% 455
2017
Q3
$7.81M Sell
66,629
-28,800
-30% -$3.68M 0.03% 512
2017
Q2
$12.4M Buy
95,429
+1,000
+1% +$125K 0.06% 368
2017
Q1
$12.8M Buy
94,429
+75,529
+400% +$11.4M 0.06% 353
2016
Q4
$2.71M Buy
18,900
+13,500
+250% +$1.72M 0.01% 705
2016
Q3
$638K Buy
5,400
+4,200
+350% +$505K ﹤0.01% 975
2016
Q2
$127K Sell
1,200
-34,100
-97% -$3.8M ﹤0.01% 1221
2016
Q1
$3.93M Sell
35,300
-26,153
-43% -$3.31M 0.02% 618
2015
Q4
$9.62M Buy
+61,453
New +$8.95M 0.04% 392
2015
Q3
Sell
-5,840
Closed -$1.02M 1520
2015
Q2
$1.02M Sell
5,840
-1,160
-17% -$209K ﹤0.01% 958
2015
Q1
$1.21M Sell
7,000
-6,550
-48% -$999K 0.01% 907
2014
Q4
$1.75M Sell
13,550
-37,450
-73% -$4.83M 0.01% 829
2014
Q3
$6.56M Buy
51,000
+8,100
+19% +$835K 0.03% 473
2014
Q2
$3.8M Buy
42,900
+17,730
+70% +$1.71M 0.02% 626
2014
Q1
$2.37M Sell
25,170
-67,330
-73% -$6.89M 0.01% 724
2013
Q4
$10.5M Sell
92,500
-187,400
-67% -$16.9M 0.05% 373
2013
Q3
$22.1M Sell
279,900
-59,160
-17% -$4.32M 0.11% 216
2013
Q2
$22.3M Buy
+339,060
New +$21.8M 0.12% 195

Other funds holding UTHR